QURE: The pinnacle art of technical analysisQURE: The pinnacle art of technical analysis
-Beautiful chart with the logical structure, candle pattern, and also with volumes.
What will be next?
US STOCKS- WALL STREET DREAM- LET'S THE MARKET SPEAK!
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.925 USD
−239.56 M USD
27.12 M USD
49.50 M
About uniQure N.V.
Sector
Industry
CEO
Matthew C. Kapusta
Website
Headquarters
Amsterdam
Founded
2012
ISIN
NL0010696654
FIGI
BBG00JVRN0J8
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.
$QURE Is A Hight Tight Flag - Here's How I Plan To Trade ItOf course I have no idea how the price of NASDAQ:QURE is going to open Monday morning, but if it opens within the body of Friday's candle or a little lower, I'll buy it two times as it breaks above 18.13 and then 18.50.
I'll set my stop to the low of the day and see what develops. Having moved up
Qure.NYSE Trend Cloud StudyuniQuire released some great Potential results from their latest Drugs Evaluation Results.
The markets responded positively. However soon retraced.
Was this just Hype?
The retracement is now down to the FIB 0.318 level.
The latest Market Analysts are showing a huge Upside Potential.
I Will be ho
uniQure N.V - Positive divergenceOn the above 2-week chart uniQure N.V. price action has corrected 90% without the aid of share splits. A number of reasons now exist to consider a long position. They include:
1) Price action returns to legacy support.
2) RSI resistance breakout.
3) Strong positive divergence as measured over a 2
$QURE selling seems done now and ready for a move upNASDAQ:QURE looks ready for a bounce now at $9.5 level assuming no problem in its earnings next week. I target mid teens as exit.
$QURE - UniQure - Oversold and Indicator breakout. Target $30+Entry Price: $18.90
Stop Loss: $13.00
Take Profit: $25-$30 (=25% to +50%)
Technical Analysis
- Oversold on daily and weekly charts - low RSI and William %R
- Attempting a breakout above key MA's on the daily and retracing on the weekly.
- Formed a wedge/consolidated on the daily chart
- Key br
WATCH $QUREBullish
Fundamental
- High inflationary Macro environment / Market has no fear sentiment
- Funds Accumulation
- Positive PE
- Decent PEG
- Positive P/FCF
- Strong Sector / Industry
- Biotech seems to be breaking out
Technical
- Momentum Theory Indicator - bottomed and broke out neckline
- P
QURE 2MuniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, t
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 0EE0 is 14.255 USD — it has decreased by −1.73% in the past 24 hours. Watch UNIQURE N.V. COM EUR0.05 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange UNIQURE N.V. COM EUR0.05 stocks are traded under the ticker 0EE0.
0EE0 stock has risen by 37.86% compared to the previous week, the month change is a −0.46% fall, over the last year UNIQURE N.V. COM EUR0.05 has showed a 220.82% increase.
We've gathered analysts' opinions on UNIQURE N.V. COM EUR0.05 future price: according to them, 0EE0 price has a max estimate of 70.00 USD and a min estimate of 13.00 USD. Watch 0EE0 chart and read a more detailed UNIQURE N.V. COM EUR0.05 stock forecast: see what analysts think of UNIQURE N.V. COM EUR0.05 and suggest that you do with its stocks.
0EE0 reached its all-time high on Jun 21, 2019 with the price of 81.000 USD, and its all-time low was 3.745 USD and was reached on Jul 5, 2024. View more price dynamics on 0EE0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0EE0 stock is 4.66% volatile and has beta coefficient of 1.76. Track UNIQURE N.V. COM EUR0.05 stock price on the chart and check out the list of the most volatile stocks — is UNIQURE N.V. COM EUR0.05 there?
Today UNIQURE N.V. COM EUR0.05 has the market capitalization of 771.14 M, it has increased by 45.58% over the last week.
Yes, you can track UNIQURE N.V. COM EUR0.05 financials in yearly and quarterly reports right on TradingView.
UNIQURE N.V. COM EUR0.05 is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
0EE0 earnings for the last quarter are −1.49 USD per share, whereas the estimation was −0.65 USD resulting in a −128.21% surprise. The estimated earnings for the next quarter are −1.00 USD per share. See more details about UNIQURE N.V. COM EUR0.05 earnings.
UNIQURE N.V. COM EUR0.05 revenue for the last quarter amounts to 5.22 M USD, despite the estimated figure of 17.94 M USD. In the next quarter, revenue is expected to reach 6.36 M USD.
0EE0 net income for the last quarter is −73.26 M USD, while the quarter before that showed −44.38 M USD of net income which accounts for −65.08% change. Track more UNIQURE N.V. COM EUR0.05 financial stats to get the full picture.
No, 0EE0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 26, 2025, the company has 209 employees. See our rating of the largest employees — is UNIQURE N.V. COM EUR0.05 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNIQURE N.V. COM EUR0.05 EBITDA is −179.47 M USD, and current EBITDA margin is −632.89%. See more stats in UNIQURE N.V. COM EUR0.05 financial statements.
Like other stocks, 0EE0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNIQURE N.V. COM EUR0.05 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UNIQURE N.V. COM EUR0.05 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UNIQURE N.V. COM EUR0.05 stock shows the buy signal. See more of UNIQURE N.V. COM EUR0.05 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.